AGEN - アジェナス (Agenus Inc.)

AGENのニュース

   Agenus Inc. Expected to Post FY2021 Earnings of ($0.27) Per Share (NASDAQ:AGEN)  2021/10/27 12:32:42 Transcript Daily
Agenus Inc. (NASDAQ:AGEN) Research analysts at Jefferies Financial Group boosted their FY2021 EPS estimates for Agenus in a note issued to investors on Monday, October 25th. Jefferies Financial Group analyst K. Shi now forecasts that the biotechnology company will post earnings per share of ($0.27) for the year, up from their previous forecast of []
   Q3 2021 EPS Estimates for Agenus Inc. (NASDAQ:AGEN) Cut by B. Riley  2021/10/27 11:00:56 Dakota Financial News
Agenus Inc. (NASDAQ:AGEN) Stock analysts at B. Riley dropped their Q3 2021 EPS estimates for Agenus in a note issued to investors on Monday, October 25th. B. Riley analyst M. Mamtani now forecasts that the biotechnology company will earn $0.55 per share for the quarter, down from their prior estimate of $0.57. B. Riley []
   Agenus (NASDAQ:AGEN) Stock Price Down 4.2%  2021/10/25 17:42:49 Transcript Daily
Agenus Inc. (NASDAQ:AGEN)s stock price was down 4.2% on Monday . The company traded as low as $3.81 and last traded at $3.84. Approximately 134,549 shares changed hands during trading, a decline of 97% from the average daily volume of 4,077,423 shares. The stock had previously closed at $4.01. A number of analysts recently weighed []
   Medical sectors Agenuss (NASDAQ:AGEN) Buy rating Reiterated by B. Riley  2021/10/25 17:38:00 Stock Market Daily
Agenus (NASDAQ:AGEN)s stock had its Buy rating Reiterated by by analysts at $11.00 in a research report issued to clients and investors. The post Medical sectors Agenuss (NASDAQ:AGEN) Buy rating Reiterated by B. Riley appeared first on .
   Agenus (NASDAQ:AGEN) Stock Rating Reaffirmed by B. Riley  2021/10/25 12:40:41 Dakota Financial News
Agenus (NASDAQ:AGEN)s stock had its buy rating reiterated by analysts at B. Riley in a research report issued to clients and investors on Monday, The Fly reports. They presently have a $11.00 price objective on the biotechnology companys stock, down from their prior price objective of $12.00. B. Rileys price objective points to a potential []
   Agenus to Participate in the Raymond James 2021 Human Health Innovation Conference  2021/06/21 13:00:00 Intrado Digital Media
LEXINGTON, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Jennifer Buell, PhD, President and COO of Agenus, will present at the Raymond James 2021 Human Health Innovation Conference on Tuesday, June 22, 2021 from 8:40 a.m. to 9:10 a.m. ET.
   Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer  2021/06/17 14:23:02 Business Insider Markets
The FDA has accepted for review Agenus Inc''s (NASDAQ: AGEN ) marketing application seeking approval for
   FDA accepts Agenus'' balstilimab BLA under "priority review" status  2021/06/17 12:45:02 Seeking Alpha
   Market Mover: Agenus Inc. (NASDAQ:AGEN), Devon Energy Corporation (NYSE:DVN)  2021/06/13 21:10:49 Stock Equity
Agenus Inc. (NASDAQ:AGEN) with the stream of 0.97% also noticed, India Devon Energy Corporation (NYSE:DVN) encountered a rapid change of 0.45% in the last hour of Fridays trading session. Agenus The post Market Mover: Agenus Inc. (NASDAQ:AGEN), Devon Energy Corporation (NYSE:DVN) appeared first on Stocks Equity .
   Analysts Top Healthcare Picks: Springworks Therapeutics (SWTX), Agenus (AGEN)  2021/06/07 13:15:17 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Springworks Therapeutics (SWTX) and Agenus The post Analysts Top Healthcare Picks: Springworks Therapeutics (SWTX), Agenus (AGEN) appeared first on Smarter Analyst .
   Market Mover: Agenus Inc. (NASDAQ:AGEN), Devon Energy Corporation (NYSE:DVN)  2021/06/13 21:10:49 Stock Equity
Agenus Inc. (NASDAQ:AGEN) with the stream of 0.97% also noticed, India Devon Energy Corporation (NYSE:DVN) encountered a rapid change of 0.45% in the last hour of Fridays trading session. Agenus The post Market Mover: Agenus Inc. (NASDAQ:AGEN), Devon Energy Corporation (NYSE:DVN) appeared first on Stocks Equity .
   Analysts Top Healthcare Picks: Springworks Therapeutics (SWTX), Agenus (AGEN)  2021/06/07 13:15:17 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Springworks Therapeutics (SWTX) and Agenus The post Analysts Top Healthcare Picks: Springworks Therapeutics (SWTX), Agenus (AGEN) appeared first on Smarter Analyst .
   Agenus/Bristol-Myers Squibb Deal Makes For A Strong Buy  2021/05/26 07:42:47 Seeking Alpha
   Agenus (AGEN) Soars on Global License Deal With Bristol-Myers  2021/05/22 21:20:55 Yahoo Finance
Agenus (AGEN) Soars on Global License Deal With Bristol-Myers Yahoo Finance
   Agenus Inc Shares Close the Week 29.7% Higher - Weekly Wrap  2021/05/21 22:30:00 Kwhen Finance
Agenus Inc (AGEN) shares closed this week 29.7% higher than it did at the end of last week. The stock is currently up 31.8% year-to-date, up 67.6% over the past 12 months, and up 12.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $4.50 and as low as $3.22 this week.Trading volume this week was 78.4% lower than the 10-day average and 31.4% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2063.2% The company's stock price performance over the past 12 months lags the peer average by -34.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

calendar